Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

BACKGROUND: The World Health Organization recommends that primaquine should be given once weekly for 8-weeks to patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase (G6PD) deficiency, but data on its antirelapse efficacy and safety are limited. METHODS: Within the context of...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Walter R. J., Meagher, Niamh, Ley, Benedikt, Thriemer, Kamala, Bancone, Germana, Satyagraha, Ari, Assefa, Ashenafi, Chand, Krisin, Chau, Nguyen Hoang, Dhorda, Mehul, Degaga, Tamiru S., Ekawati, Lenny L., Hailu, Asrat, Hasanzai, Mohammad Anwar, Naddim, Mohammad Nader, Pasaribu, Ayodhia Pitaloka, Rahim, Awab Ghulam, Sutanto, Inge, Thanh, Ngo Viet, Tuyet-Trinh, Nguyen Thi, Waithira, Naomi, Woyessa, Adugna, Dondorp, Arjen, von Seidlein, Lorenz, Simpson, Julie A., White, Nicholas J., Baird, J. Kevin, Day, Nicholas P., Price, Ric N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482257/
https://www.ncbi.nlm.nih.gov/pubmed/37672548
http://dx.doi.org/10.1371/journal.pntd.0011522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482257/
https://www.ncbi.nlm.nih.gov/pubmed/37672548
http://dx.doi.org/10.1371/journal.pntd.0011522

Ejemplares similares